To confirm the hypothesis that loss-of-function mutant of PCSK9 would causes hypocholesterolemia, Cohen et al. [55] sequenced the coding region of PCSK9 in individuals with low levels of plasma LDL-cholesterol (<5th percentile). This evidence concerns the gene PCSK9 and Hypocholesterolemia.